SynthesisJournal for immunotherapy of cancer2024

Comparison of CAR T-cell and bispecific antibody as third-line or later-line treatments for multiple myeloma: a meta-analysis.

Xiaojie Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.